$0.08
4.05% yesterday
Nasdaq, Jul 30, 08:45 pm CET
ISIN
US91059D1000
Symbol
UEEC

United Health Products Stock price

$0.08
-0.01 13.13% 1M
+0.02 30.31% 6M
+0.03 59.51% YTD
-0.10 54.71% 1Y
-0.32 78.83% 3Y
-0.69 89.07% 5Y
-0.01 5.68% 10Y
-0.42 83.06% 20Y
Nasdaq, Closing price Wed, Jul 30 2025
+0.00 3.93%
ISIN
US91059D1000
Symbol
UEEC

Key metrics

Basic
Market capitalization
$21.8m
Enterprise Value
$22.9m
Net debt
$1.1m
Cash
$0.0
Shares outstanding
257.1m
Valuation (TTM | estimate)
P/E
negative | -
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-905.1%
Return on Equity
81.9%
ROCE
172.9%
ROIC
-
Debt/Equity
-0.4
Financials (TTM | estimate)
Revenue
$0.0 | -
EBITDA
$-3.0m | -
EBIT
$-3.0m | -
Net Income
$-3.1m | -
Free Cash Flow
$-1.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
-63.9% | -
EBIT
-64.1% | -
Net Income
-59.6% | -
Free Cash Flow
48.5%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$0.0
FCF per Share
$0.0
Short interest
-
Employees
4
Rev per Employee
$0.0
Show more

Is United Health Products a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,020 stocks worldwide.

Financial data from United Health Products

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 2.72 2.72
109% 109%
-
- Research and Development Expense 0.36 0.36
28% 28%
-
-2.95 -2.95
64% 64%
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -2.96 -2.96
64% 64%
-
Net Profit -3.08 -3.08
60% 60%
-

In millions USD.

Don't miss a Thing! We will send you all news about United Health Products directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. It also offers HemoStyp to control bleeding. The company was founded on February 28, 1997 and is headquartered in Mount Laurel, NJ.

Head office United States
CEO Brian Thom
Employees 4
Founded 1997
Website uhpcorp.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today